News • Large study
Blood test for Alzheimer’s highly accurate
When combined with genetic risk factors, the test was up to 93 percent accurate at identifying people at risk of Alzheimer's dementia.
Screening
News • Adaptable for screening
An optical methodology for rapid detection of COVID-19
The tool has made it possible to detect SARS-CoV-2 in exudate from symptomatic patients with a sensitivity of 100% and a specificity of 87.5%
News • Screening performance
MRI reduces breast cancer deaths in women with 3 risk genes
Annual MRI screenings starting at ages 30-35 may reduce breast-cancer mortality by more than 50% among women who carry certain genetic changes in three genes, according to a new modeling analysis.
News • Reduced harm, reduced costs
Prostate cancer: MRI and blood test improve screening
The combination of a novel blood test and magnetic resonance imaging can reduce overdiagnosis of low-risk cancers as well as societal costs in prostate cancer screening, according to a new study.
News • Blood clot screening
AI could help detect pulmonary embolisms with ECG data
A new pilot study suggests that machine learning algorithms which fuse electrocardiogram (ECG) and electronic health record data may help doctors screen for dangerous, lung-clogging blot clots.
Sponsored • Lab diagnostics
Molecular scalable solutions for laboratories of every size
One size does not fit all when it comes to diagnostics. Different diagnostic locations need solutions that meet their needs, whether for on-demand testing in a healthcare setting or a laboratory managing population screening. Finding the right solution can be a challenge especially when the future may change what a laboratory needs, Hologic Inc. reports.
Article • Mass spec, qPCR and more
Newborn screening: early detection – new diagnostic possibilities
Since its introduction around 60 years ago, the screening of newborn babies for immune, hormone and metabolic disorders has prevented many people from experiencing severe disease progression. The scope of systematic early testing has been significantly enhanced through mass spectrometry (MS). In our interview, Professor Uta Ceglarek, one of the driving forces behind the introduction of MS…
Article • Over-detection and biopsies
New procedures for prostate cancer screening
Organised screening enabling early detection and treatment of prostate cancer can reduce death by an impressive 20%, based on 16 years of findings of over 160,000 men participating in the landmark European Randomised Study of Screening for Prostate Cancer (ERSPC).
News • Colorectal cancer study
Covid-19 pandemic slashes CRC diagnoses by over 40%
The number of colorectal cancer (CRC) cases diagnosed fell dramatically by 40% in a year during the Covid-19 pandemic, new research presented at United European Gastroenterology (UEG) Week Virtual 2021 has shown. The research, which was conducted across multiple hospitals in Spain, compared data from the first year of the Covid-19 pandemic with data from the previous year. Of 1,385 cases of CRC…
News • Additional costs that pay off
For women with dense breasts, MRIs are cost effective for detecting breast cancer
New research indicates that MRIs are cost effective for detecting breast cancer for women with very dense breasts detected by mammography. About 10% of women have extremely dense breasts, and current mammography screening guidelines do not recommend additional imaging tests unless there is a strong family history or genetic risk for breast cancer. Such women face two problems. They have increased…
News • Insight report
More screening and secondary prevention needed
For World Patient Safety Day, Health First Europe (HFE) published a comprehensive insight report on five disease areas that affect millions of European citizens each year and how the European Union could and should do a better job for its citizens.
Article • Discussing benefits and flaws
AI in cardiology: a marriage made in heaven – or hell?
The role of Artificial Intelligence (AI) is one of the most divisive issues in cardiology. Two leading experts argue the pros and cons of its use, exploring its benefits and advantages to cardiac care, as well as highlighting the pitfalls and shortcomings of AI, while underlining the need for clear guidelines and regulations for its use going forward.
News • Eye disease prevention
Using AI to screen for glaucoma
Scientists from the Nanyang Techniogical University (NTU) Singapore, in collaboration with clinicians at Tan Tock Seng Hospital (TTSH) in Singapore, have developed a novel method that uses artificial intelligence (AI) to screen for glaucoma, a group of eye diseases that can cause vision loss and blindness through damage to the optic nerve at the back of the eye. Glaucoma is often called ‘the…
News • Stockholm3 test to reduce MRI
New blood test to improve prostate cancer screening
Researchers at Karolinska Institutet recently reported that magnetic resonance imaging (MRI) could reduce overdiagnoses and thereby improve prostate cancer screening. Now, the same research group has published a study in The Lancet Oncology, which shows that the addition of a novel blood test, the Stockholm3 test, can reduce the number of MRIs performed by a third while further preventing the…
Sponsored • Breast cancer backlog
Getting cancer screening programmes back on track with AI and digitisation
The Covid-19 pandemic continues to impact people’s health across the world. This goes beyond the disease itself, as healthcare systems adapt how they provide services. Routine screening has been severely affected with screening programmes reduced or paused.
Article • Screening, early detection, treatment optimisation
AI techniques advancing oncology care
Cancer care and the treatment clinicians can offer patients is being increasingly enhanced by Artificial Intelligence (AI). The technology has a role in diagnosis, with algorithms trained to design and deliver patient care, can match patients to clinical trials they may benefit from, and even help predict outcomes and those at greatest risk.
News • Oncology early detection tool
Blood test for 50+ types of cancer promising for screening
Final results from a study of a blood test that can detect more than 50 types of cancer have shown that it is accurate enough to be rolled out as a multi-cancer screening test among people at higher risk of the disease, including patients aged 50 years or older, without symptoms. In a paper published in the cancer journal Annals of Oncology, researchers report that the test accurately detected…
Article • Personalized medicine
Time to consider risk-based breast cancer screening protocols
In the emerging era of personalized medicine, risk-based breast cancer screening protocols may be better than the one-size-fits all approach. It’s time to consider adopting them, Jack Cuzick, Ph.D., said in the President’s Address of the 2021 Society of Breast Imaging/American College of Radiology Breast Imaging Symposium.
News • Non-invasive
LUCA device is ready for better thyroid cancer screening
The EU-funded consortium Laser and Ultrasound Co-analyzer for Thyroid Nodules (LUCA) has developed a non-invasive, low-cost device that brings a new solution for thyroid cancer screening.
News • Campaign to reprioritise breast health
Breast cancer: "Screening routine" to combat Covid-related backlog
One of the negative impacts of the coronavirus pandemic has been the suspension or postponement of many cancer screening services. Each year, these services help prevent and detect the presence of cancer at an early stage; timely diagnosis and care are crucial in preventing the spread of cancer. The National Screening Observatory has confirmed this, reporting alarming statistics: during the first…
News • Combining common risk factors
Deep learning enables dual screening for cancer and CVD
Heart disease and cancer are the leading causes of death in the United States, and it’s increasingly understood that they share common risk factors, including tobacco use, diet, blood pressure, and obesity. Thus, a diagnostic tool that could screen for cardiovascular disease while a patient is already being screened for cancer has the potential to expedite a diagnosis, accelerate treatment, and…
Sponsored • Mammography
Advancing the Breast Continuum of Care
The pandemic has presented healthcare systems with new challenges, resulting in backlogs of routine screenings and delayed procedures which threaten the health and wellbeing of patients, as well as the ability of facilities to serve their communities. In order to address these widespread issues, we need to ensure that healthcare professionals are able to operate with precision, confidence and…
News • Mammography support
AI solution may reduce interval breast cancer rates
Medical technology company iCAD, Inc. announced that ProFound AI for 2D Mammography might notably reduce the risk of interval breast cancer, according to a new retrospective analysis. The aim of the study was to determine if adding AI to reading mammography as a supportive tool may help in decreasing the interval cancer rate in population-based organized mammography screening programs in Germany.
Article • Digital pathology
AI delivers cervical cancer screening to rural areas of Kenya
Experts from Sweden, Finland and Kenya are using digital microscopy combined with Artificial Intelligence (AI) to deliver a rapid and effective cervical screening service to rural locations in Kenya. The project sees AI and digital diagnostics bridge the gap between low-resource settings and the availability of centralised AI-enhanced expertise and pathology services, located in larger cities in…
News • HPV testing advances
Cervical cancer screening: Emerging tech to replace Pap smears
Emerging technologies can screen for cervical cancer better than Pap smears and, if widely used, could save lives both in developing nations and parts of countries, like the United States, where access to health care may be limited. In Biophysics Reviews, by AIP Publishing, scientists at Massachusetts General Hospital write advances in nanotechnology and computer learning are among the…